CDK4

E561032

CDK4 is a cyclin-dependent kinase that regulates cell cycle progression and is a key therapeutic target in certain cancers.

All labels observed (4)

Label Occurrences
cyclin-dependent kinase 4 2
CDK4 canonical 1
CDK4 gene 1

How this entity was disambiguated

Statements (65)

Predicate Object
instanceOf cyclin-dependent kinase
human gene
protein kinase
alternativeName PSK-J3
cell division protein kinase 4
linked to: CDK4
associatedWithDisease breast cancer
glioblastoma
liposarcoma
melanoma
non-small cell lung cancer
biologicalProcess G1 phase of mitotic cell cycle
G1/S transition of mitotic cell cycle
cell cycle checkpoint regulation
negative regulation of cell cycle arrest
phosphorylation of RB1 protein
regulation of cell proliferation
cellularComponent cyclin-dependent protein kinase holoenzyme complex
cytoplasm
nucleus
chromosomalBand 12q14
clinicalBiomarkerRole predictive biomarker for CDK4/6 inhibitor response
conservedIn Danio rerio
Mus musculus
Rattus norvegicus
encodedByGene CDK4 gene
linked to: CDK4
enzymeCommissionNumber EC 2.7.11.22
formsComplexWith cyclin D1
cyclin D2
cyclin D3
fullName cyclin-dependent kinase 4
linked to: CDK4
geneType protein-coding gene
hasEnsemblGeneID ENSG00000135446
hasEntrezGeneID 1019
hasHGNCID HGNC:1773
hasUniProtID P11802
inhibitedByDrug abemaciclib
linked to: Verzenio

lenvatinib (weak off-target)
palbociclib
linked to: Ibrance

ribociclib
linked to: trilaciclib

trilaciclib
locatedOnChromosome human chromosome 12
molecularFunction ATP binding
cyclin-dependent protein serine/threonine kinase activity
serine/threonine protein kinase activity
oncogenicMechanism activating mutation
gene amplification
overexpression
organism Homo sapiens
pathway G1/S transition pathway
cell cycle pathway
p16INK4A-CDK4-RB pathway
postTranslationalModification phosphorylation at threonine 172
regulatedBy CDKN2A (p16INK4A)
CDKN2B (p15INK4B)
CDKN2C (p18INK4C)
CDKN2D (p19INK4D)
requiresBindingPartner D-type cyclins
requiresCofactor Mg2+
roleInCancerBiology drives cell cycle progression from G1 to S phase
promotes tumor cell proliferation when deregulated
substrate RB1
RBL1
RBL2
therapeuticTargetIn advanced breast cancer
hormone receptor-positive breast cancer

How these facts were elicited

Referenced by (5)

Full triples — surface form annotated when it differs from this entity's canonical label.

Verzenio targets CDK4
Ibrance targets cyclin-dependent kinase 4
linked to: CDK4
CDK4 fullName cyclin-dependent kinase 4
linked to: CDK4
CDK4 encodedByGene CDK4 gene
linked to: CDK4
CDK4 alternativeName cell division protein kinase 4
linked to: CDK4